Clinical trial Recruiting at 1 site Interventional Ages 45 and up

Trigger-point steroid injections versus hip joint steroid injections for hip osteoarthritis

Official title: Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Musculoskeletal Pain(CMP), Chronic Migraine and Cervicogenic Headache

Run by Beijing Tiantan Hospital · NCT07347041 · Data updated 2026-11-12

This test compares steroid injections into myofascial trigger points versus injections into the hip joint to see which reduces pain and improves function in people aged 45 and older with hip osteoarthritis.

Quick facts

Study typeInterventional
Ages45 Years and up
SexAll
Enrollment1036 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 1, 2026
Study endsJune 1, 2027
Registry record updatedJanuary 16, 2026
Trial IDNCT07347041 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 45 or older with radiographic hip osteoarthritis (Kellgren–Lawrence grade 1–4), chronic hip pain for more than 3 months, at least one palpable myofascial trigger point, NRS ≥3 despite conservative treatment, and able to give informed consent.

Probably not a fit

Patients with corticosteroid allergy, active inflammatory rheumatic disease, recent intra-articular injection, severe organ dysfunction, long-term systemic steroid therapy, or other major exclusion criteria are unlikely to derive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, controlled study with blinded outcome assessment using a non-inferiority design to compare glucocorticoid injections at myofascial trigger points (MTrPs) versus intra-articular hip injections. Participants are randomly assigned to receive either MTrP injections or joint-cavity injections and are followed for two years. Key outcome measures include pain intensity (NRS), joint function and stiffness (WOMAC), patient-reported outcomes, and safety events. The trial tests whether the simpler MTrP injection approach can provide comparable long-term symptom relief to standard intra-articular treatment.

Why it matters

Potential benefit: If successful, this could offer a simpler, potentially safer injection option that provides similar or better long-term pain relief and improved function compared with standard intra-articular steroid injections.

How similar studies have gone: Previous domestic and international studies have reported that glucocorticoid injections at MTrPs can relieve pain in knee osteoarthritis and other chronic musculoskeletal pain conditions, but randomized long-term data specifically for hip osteoarthritis remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of hip osteoarthritis with radiographic evidence of osteoarthritis (Kellgren-Lawrence grade 1-4) confirmed by at least two orthopedic surgeons, pain specialists, or general practitioners, with physical examination confirming at least one myofascial trigger point;
* Disease duration exceeding 3 months;
* Age ≥ 45 years;
* Numerical Rating Scale (NRS) score ≥ 3 points despite prior conservative pharmacological treatment;
* Signed informed consent form.

Exclusion Criteria:

* History of allergy to trial medications such as corticosteroids;
* Alcohol abuse; long-term use of opioids (exceeding 2 weeks or more than 3 days per week for over 1 month); suspected use of sedative or analgesic medications; patients on long-term steroid therapy;
* Severe neurological disorders, significant hepatic or renal dysfunction, heart failure, coagulation abnormalities, gastric ulcer, diabetes, inflammatory rheumatic diseases, etc.;
* Intra-articular injection within the past 6 months or planned joint replacement surgery;
* Inability to use pain assessment scales;
* Presence of local or systemic infection;
* Pregnant or lactating patients.

Where it's running

  • Beijing Tiantan Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.